WHOLESALE BULK SUPPLY · A2LA-ACCREDITED HPLC VERIFIED

Stillwater BioLabs
GH-Axis Receptor Research

CJC-1295 (with DAC)

Request pricing

Pricing is shown to approved wholesale accounts.

Apply for a wholesale account

CJC-1295 with DAC (Drug Affinity Complex) modification, supplied as a lyophilized reference standard for extended-half-life GHRH-receptor research. Distinct from the no-DAC form in pharmacokinetic profile.

Size:

Minimum order: 10 units per compound, across any mix of sizes.

VisaMastercardAmerican Express

Pay with Visa, Mastercard, or AMEX · ACH bank transfer saves 5%

Cold-chain shipping via UPS, with tracking provided. Freight and lead time are confirmed on your quote.

Third-party tested

For laboratory research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use.

Supplied to qualified labs and institutional buyers. Institutional use & buyer eligibility

About CJC-1295 (with DAC)

CJC-1295 with DAC is a synthetic 30-amino-acid GHRH analog covalently modified with a Drug Affinity Complex side chain that binds endogenous albumin in preclinical models, extending the molecule's serum half-life from minutes (the no-DAC form) to days. Supplied as a lyophilized reference standard for in-vitro GHRH-receptor binding assays, half-life characterization, and pharmacokinetic method development. Researchers use this compound for extended-pulse-frequency GH-axis studies and analytical chromatographic reference. Not for use in any living organism.

Product specifications for CJC-1295 (with DAC)
PropertyValue
Product NameCJC-1295 (with DAC)
FormLyophilized Powder
AppearanceWhite to off-white powder
Purity≥99%
CAS Number863288-34-0
Molecular Weight3647.27 g/mol
StorageStore at -20°C. Reconstituted: 2-8°C, use within 21 days.

Disclaimer: The information provided is for research reference only and does not constitute medical advice. Products are sold strictly for in-vitro research use.

Related Products